Corrigendum to âNovel domains of the prokaryotic two-component signal transduction systemsâ

Michael Y. Galperin; A. N. NIKOL'SKAYA; Eugene V Koonin

doi:10.1111/j.1574-6968.2001.tb10887.x

RDLNetworkEkosistem

Hakkımızda SSS

Giriş yap Başla

Hakkımızda SSS Gizlilik Şartlar İletişim

Corrigendum to âNovel domains of the prokaryotic two-component signal transduction systemsâ — Michael Y. Galperin (2001) | RDL Network

Back

Home
Publications
Corrigendum to âNovel domains of the prokaryotic two-component signal transduction systemsâ

Shared by

Eugene V Koonin

Corrigendum to âNovel domains of the prokaryotic two-component signal transduction systemsâ

Corrigendum 2001 en

Authors

MG
Michael Y. Galperin
AN
A. N. NIKOL'SKAYA
EK
Eugene V Koonin
National Center for Biotechnology Information

Abstract

1 min read

Bacteria Mesorhizobium loti 7036 6752 2 36 10 62 15 2 57 32 18 1 Pseudomonas aeruginosa 6264 5565 6 41 9 62e 19 11 75 33 21 3 Escherichia coli 4639 4289 3 14 9 28e 5 6 32 19 17 0 Bacillus subtilis 4215 4100 10 14 3 33e 0 1 36 4 3 0 Bacillus halodurans 4202 4066 8 15 5 36e 2 1 48 4 2 2 Mycobacterium tuberculosis 4412 3918 0 2 3 15 0 0 13 1 2 0 Vibrio cholerae 4033 3827 20 30 5 41e 11 10 49 41 22 9 Caulobacter crescentus 4017 3737 3 26 6 62 28 2 45 11 10 0 Synechocystis sp. 3573 3169 2 26 28 42e 17 7 41e 23 13 2 Mycobacterium leprae 3268 2720 0 3 1 5 0 0 5 3 2 0 Xylella fastidiosa 2679 2766 0 4 1 14 5 2 20 3 3 1 Deinococcus radiodurans 2649 2580 0 7 3 21 5 0 25 16 5 4 Lactococcus lactis 2365 2266 0 2 1 7 0 0 7 0 0 0 Neisseria meningitidis 2184 2121 0 1 1 5 0 0 5 0 0 0 Thermotoga maritima 1861 1846 6 4 2 9 0 1 12 9+2f 0 9 Haemophilus in£uenzae 183

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1111/j.1574-6968.2001.tb10887.x
Year: 2001
Published: —
Language: en

Corrigendum Details

Volume: 204
Issue: 1
Link Of The Paper: https://doi.org/10.1111/j.1574-6968.2001.tb10887.x

Timeline

Created:June 19, 2026

Related publications

Article2007

Changes in lymphocytic populations and autoantibodies resulting from sunitinib treatment of metastatic renal cell carcinoma (mRCC).

Alexandra Karadimou, Marinos Tsiatas, N. Gavalas, G. Lainakis, Evangelos Terpos, Meletios A Dimopoulos, Aristotle Bamias

Corrigendum to âNovel domains of the prokaryotic two-component signal transduction systemsâ

Abstract

Discussion(0)

Related publications

Long-Term Follow-Up of Multiple Myeloma (MM) Patients (pts) with Osteonecrosis of the Jaw (ONJ).

Patient-reported acute and chronic toxicities from adjuvant therapies post resection of melanoma.

Financial toxicity and employment outcomes in people with melanoma receiving adjuvant therapies.

Decision support for sulphur applications to cereals

Changes in lymphocytic populations and autoantibodies resulting from sunitinib treatment of metastatic renal cell carcinoma (mRCC).